We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Nasal Surgery May Help Alleviate Chronic Headaches

By HospiMedica International staff writers
Posted on 20 Dec 2018
A new study suggests that functional nasal surgery to relieve obstructed breathing can reduce or eliminate chronic headaches in selected patients.

Researchers at the University of Wisconsin (WISC; Madison, USA) and Cairo University (Egypt) conducted a systematic literature review in order to determine the validity of the hypothesis that nasal surgery to remove mucosal contact points can reduce symptoms in chronic headache patients. More...
In all, the researchers identified 39 articles involving 1,577 patients who underwent surgery to treat mucosal contact points. Septoplasty and turbinate reduction were the most commonly performed procedures, often in combination with endoscopic sinus surgery (ESS).

An analysis of the combined data demonstrated an improvement in the reported severity of symptoms, with 85% of the patients reporting partial or complete resolution of headaches postoperatively. Average visual analogue scale (VAS) headache scores and number of headache days in patients undergoing nasal surgery was reduced from 7.4 and 22 days to 6.4 and 4.2 days, respectively. Improvement in headache symptoms was associated with a positive response to preoperative anesthetic testing, and with inclusion of ESS as part of the procedure. The study was published in the December 2018 issue of Plastic and Reconstructive Surgery.

“Taken together, these results underscore the importance of a thorough diagnostic workup to help tailor individualized surgical treatment to each patient's unique anatomy,” concluded lead author Ahmed Afifi, MD, of WISC, and colleagues. “Nasal mucosal contact points may be a viable surgical target to help improve headaches in appropriately selected patients. The good responses to nasal surgery suggest an important relationship between intranasal anatomy and headache feedback loops.”

The cause of rhinogenic headache was identified in 1988 as mechanical contact between two mucosal surfaces that creates a sensory stimulus responsible for the headache symptoms. Relieving septal deviations and sinonasal anatomic abnormalities contacting the nasal wall, middle or inferior turbinate, concha bullosa, pneumatized superior turbinate, and any other visualized mucosal contact point is considered the ideal treatment method to relieve these headaches.

Related Links:
University of Wisconsin
Cairo University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.